Company · CIK 1434265
GENMAB A/S
| CIK | 1434265 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | Denmark |
| Listed | GMAB (Nasdaq), GNMSF (OTC) |
| First annual or quarterly report | 2020-03-30 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-231777 | 2019-05-28 | 2019-07-19 | 5 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-07-15 | EFFECTDeclared effective | 333-288500 | 9999999995-25-002257 |
| 2019-07-19 | 424B4Final prospectus | 333-231777 | 0001047469-19-004269 |
| 2019-07-17 | EFFECTDeclared effective | 333-231777 | 9999999995-19-001624 |
| 2019-07-16 | F-1/AAmendment | 333-231777 | 0001047469-19-004195 |
| 2019-07-09 | F-1/AAmendment | 333-231777 | 0001047469-19-004052 |
| 2019-05-28 | F-1Registration filed | 333-231777 | 0001047469-19-003334 |
| 2019-02-05 | DRSDraft made public | 377-02489 | 0000912057-19-000036 |
| 2013-05-29 | EFFECTDeclared effective | 333-188759 | 9999999995-13-001659 |